Resumo

SANCHA-ESCUDERO, Victoria et al. SARS-CoV-2 vaccine (COVID-19) and chronic kidney disease. Enferm Nefrol [online]. 2021, vol.24, n.2, pp.117-127.  Epub 13-Set-2021. ISSN 2255-3517.  https://dx.doi.org/10.37551/s2254-28842021012.

The most recent evidence indicates that chronic kidney disease is the comorbidity with the highest risk of developing severe disease due to SARS-CoV-2, coronavirus 2019 (COVID-19). Many scientific societies have advocated for vaccination of patients with chronic kidney disease as a priority, due to this high vulnerability. In Spain, the fifth update of the COVID-19 vaccination strategy published by the Interterritorial Health Council included CKD patients in group 7 (people with very high-risk conditions). This manuscript describes the types of vaccines according to mechanism of action, the vaccines currently approved by the European Medicines Agency (EMA) and information related to the vaccination process (preparation, administration and follow-up), as well as aspects to be taken into account in patients with CKD.

Palavras-chave : COVID-19 vaccines; renal dialysis; chronic kidney disease; vaccination.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )